Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anisha Doshi

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 10, 2022
Serum neurofilament light and MRI predictors of cognitive decline in patients with secondary progressive multiple sclerosis: Analysis from the MS-STAT randomised controlled trialThomas Williams, Carmen Tur, Arman Eshaghi, et al.
Trials|August 9, 2022
Optimising recruitment in clinical trials for progressive multiple sclerosis: observational analysis from the MS-SMART and MS-STAT2 randomised controlled trialsThomas Williams, Sarah Alexander, James Blackstone, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 29, 2014
Plasma melatonin is reduced in Huntington's diseaseEirini Kalliolia, Edina Silajdžić, Rajasree Nambron, et al.
The Lancet. Neurology|May 30, 2020
MS-SMART study: systematic sampling bias concerns - Authors' replyJeremy Chataway, Floriana De Angelis, Peter Connick, et al.
European Journal of Neurology|February 10, 2026
Vascular Comorbidities and an Increased Comorbidity Score Are Associated With Disability and Disability Progression in Secondary Progressive Multiple SclerosisNevin A John, Yingtong Li, Floriana De Angelis, et al.
European Journal of Neurology|July 9, 2025
Executive Dysfunction and Disability in SPMS: Predictive Value of the Frontal Assessment Battery in the UCLH MS-STAT2 CohortCharles Wade, Anisha Doshi, Sean Apap Mangion, et al.
Multiple Sclerosis and Related Disorders|February 8, 2025
Investigating the impact of different dichotomous definitions for cognitive impairment on functional connectivity in secondary progressive MSAnisha Doshi, Nils Muhlert, Gloria Castellazzi, et al.
Practical Neurology|November 12, 2024
Using disease-modifying treatments in multiple sclerosis: Association of British Neurologists (ABN) 2024 guidanceWaqar Rashid, Olga Ciccarelli, Siobhan M Leary, et al.
European Journal of Neurology|December 18, 2024
Vascular risk factors are associated with grey matter atrophy in secondary progressive multiple sclerosisNevin A John, Yingtong Li, Floriana De Angelis, et al.
Multiple Sclerosis and Related Disorders|November 23, 2024
Assessing the landscape and charting paths: UK neurology trainees' opinions on neuroinflammation subspecialtyTarunya Arun, Kate Petheram, Emma Tallantyre, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 10, 2022
Serum neurofilament light and MRI predictors of cognitive decline in patients with secondary progressive multiple sclerosis: Analysis from the MS-STAT randomised controlled trialThomas Williams, Carmen Tur, Arman Eshaghi, et al.
Trials|August 9, 2022
Optimising recruitment in clinical trials for progressive multiple sclerosis: observational analysis from the MS-SMART and MS-STAT2 randomised controlled trialsThomas Williams, Sarah Alexander, James Blackstone, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 29, 2014
Plasma melatonin is reduced in Huntington's diseaseEirini Kalliolia, Edina Silajdžić, Rajasree Nambron, et al.
The Lancet. Neurology|May 30, 2020
MS-SMART study: systematic sampling bias concerns - Authors' replyJeremy Chataway, Floriana De Angelis, Peter Connick, et al.
European Journal of Neurology|February 10, 2026
Vascular Comorbidities and an Increased Comorbidity Score Are Associated With Disability and Disability Progression in Secondary Progressive Multiple SclerosisNevin A John, Yingtong Li, Floriana De Angelis, et al.
European Journal of Neurology|July 9, 2025
Executive Dysfunction and Disability in SPMS: Predictive Value of the Frontal Assessment Battery in the UCLH MS-STAT2 CohortCharles Wade, Anisha Doshi, Sean Apap Mangion, et al.
Multiple Sclerosis and Related Disorders|February 8, 2025
Investigating the impact of different dichotomous definitions for cognitive impairment on functional connectivity in secondary progressive MSAnisha Doshi, Nils Muhlert, Gloria Castellazzi, et al.
Practical Neurology|November 12, 2024
Using disease-modifying treatments in multiple sclerosis: Association of British Neurologists (ABN) 2024 guidanceWaqar Rashid, Olga Ciccarelli, Siobhan M Leary, et al.
European Journal of Neurology|December 18, 2024
Vascular risk factors are associated with grey matter atrophy in secondary progressive multiple sclerosisNevin A John, Yingtong Li, Floriana De Angelis, et al.
Multiple Sclerosis and Related Disorders|November 23, 2024
Assessing the landscape and charting paths: UK neurology trainees' opinions on neuroinflammation subspecialtyTarunya Arun, Kate Petheram, Emma Tallantyre, et al.
Pageof 4